Lack of definitive evidence has not stopped exploding demand for chloroquine and hydroxychloroquine, drugs that are critical for lupus and rheumatoid arthritis patients.
Lack of definitive evidence has not stopped exploding demand for chloroquine and hydroxychloroquine, drugs that are critical for lupus and rheumatoid arthritis patients.